Trial record 1 of 1 for:
04985604
Tovorafenib (DAY101) Monotherapy or in Combination With Other Therapies for Patients With Melanoma and Other Solid Tumors
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04985604 |
|
Recruitment Status :
Recruiting
First Posted : August 2, 2021
Last Update Posted : March 29, 2024
|
Sponsor:
Day One Biopharmaceuticals, Inc.
Information provided by (Responsible Party):
Day One Biopharmaceuticals, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | July 31, 2025 |
| Estimated Study Completion Date : | December 31, 2025 |